FOSL1 and MYC are oncogenic transcription factors that contribute to the development and progression of various cancer types, including lung cancer, and their expression levels have been shown to be upregulated by the EGFR-ERK1/2 signaling pathway (Figure 6) [45,46,47,48,49,50,51]. The gene discussed is EGFR; the disease is lung cancer.